← back to search

Steven E. Bosinger

Emory University · US
🔎 Find collaborators in Virology · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Virology · Immunology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and COVID-19 Clinical Research Studies.
h-index
54
citations
11,055
works
230
NIH funding
primary concept
Biology
email

Recent publications

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
Nature Immunology 2025cited by 44position: middledoi
Diverse priming outcomes under conditions of very rare precursor B cells
Immunity 2025cited by 12position: middledoi
A multiomics recovery factor predicts long COVID in the IMPACC study
Journal of Clinical Investigation 2025cited by 3position: middledoi
Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruption
Science Translational Medicine 2025cited by 2position: middledoi
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
Journal of Allergy and Clinical Immunology Global 2025cited by 1position: middledoi
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
JCI Insight 2025cited by 1position: middledoi
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Frontiers in Medicine 2025cited by 0position: middledoi
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality
JCI Insight 2025cited by 0position: middledoi
Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates
Science 2024cited by 61position: middledoi
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications 2024cited by 57position: middledoi
The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression
Cell 2024cited by 46position: middledoi
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
Journal of Clinical Investigation 2024cited by 32position: middledoi
Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence
Nature Immunology 2024cited by 29position: middledoi
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
Cell 2023cited by 65position: middledoi
CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness
Immunity 2023cited by 39position: middledoi
TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
Nature Communications 2023cited by 37position: lastdoi
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
Science Immunology 2023cited by 28position: middledoi
Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial
Nature Communications 2023cited by 22position: middledoi
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
Nature Communications 2023cited by 17position: middledoi
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 5position: middledoi
Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life
medRxiv 2023cited by 2position: middledoi
Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates
PLoS Pathogens 2022cited by 54position: middledoi
From structure to sequence: Antibody discovery using cryoEM
Science Advances 2022cited by 49position: middledoi
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 41position: middle
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Nature 2021cited by 563position: middledoi
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination
Cell 2021cited by 276position: middledoi
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Journal of Clinical Oncology 2021cited by 242position: middledoi
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Immunity 2021cited by 91position: middledoi

Grants

Functional Omics Core Laboratory
NIH75N93025C00014-0-9999-1$2,065,4952025–2026Contact PIRePORTER
Illumina NovaSeq X Plus High Throughput DNA Sequencer for Emory University
NIH1S10OD038274-01$1,083,7502025–2026Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH2R24AI162317-05$879,6172021–2030Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH5R24AI162317-04$859,7772021–2025Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH5R24AI162317-03$859,7772021–2025Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH5R24AI162317-02$859,7772021–2025Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH1R24AI162317-01$790,6242021–2025Contact PIRePORTER
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
NIH3R24AI162317-03S1$407,5692021–2025Contact PIRePORTER
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core
NIH5U42OD011023-17$937,4672020–Contact PIRePORTER
Project 2: Innate Immunity
NIH5U19AI057266-17$509,7262020–Contact PIRePORTER
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory University
NIH1S10OD026799-01$985,0302019–2020Contact PIRePORTER
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core
NIH5U42OD011023-16$806,7502019–Contact PIRePORTER
Project 2: Innate Immunity
NIH2U19AI057266-16$329,2422019–Contact PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH1R01AI136990-01A1$862,2172018–2023PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH5R01AI136990-02$842,3422018–2023PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH5R01AI136990-05$833,1682018–2023PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH5R01AI136990-06$814,0222018–2024PIRePORTER
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core
NIH2U42OD011023-15A1$772,6892018–Contact PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH7R01AI136990-04$539,2402018–2023PIRePORTER
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
NIH5R01AI136990-03$311,1162018–2021PIRePORTER
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
NIH5R01AI128837-05$877,0872017–2023PIRePORTER
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
NIH5U24AI120134-10$1,296,1332015–2026Contact PIRePORTER
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
NIH5U24AI120134-09$1,275,3352015–2025Contact PIRePORTER
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
NIH2U24AI120134-06$681,2142015–2025Contact PIRePORTER
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
NIH5U24AI120134-07$660,9842015–2025Contact PIRePORTER

Frequent collaborators

Guido Silvestri · International AIDS Vaccine Initiative23 papers (2012–2024)Gregory K. Tharp · Emory University15 papers (2014–2024)Mirko Paiardini · Emory Healthcare12 papers (2012–2023)Ann Chahroudi · Emory University9 papers (2012–2020)Amit A. Upadhyay · Emory University8 papers (2018–2022)Thomas H. Vanderford · Emory and Henry College7 papers (2012–2018)Nirav Patel · University of Mount Olive6 papers (2013–2019)James M. Billingsley · Harvard University5 papers (2018–2020)Shane Crotty · La Jolla Institute for Immunology5 papers (2016–2022)Rama Rao Amara · Emory Healthcare5 papers (2012–2018)Bali Pulendran · Stanford University5 papers (2016–2021)Jeffrey D. Lifson · Center for Cancer Research5 papers (2013–2021)Benton Lawson · Atlanta VA Medical Center4 papers (2012–2016)Colin Havenar‐Daughton · VIR Biotechnology (United States)4 papers (2016–2019)Jacob D. Estes · MIT University4 papers (2015–2018)François Villinger · The University of Texas MD Anderson Cancer Center4 papers (2012–2021)Luca Micci · Merck & Co., Inc., Rahway, NJ, USA (United States)3 papers (2014–2021)William R. Schief · Scripps Research Institute3 papers (2018–2022)Michaela Müller‐Trutwin · Institut Pasteur3 papers (2018–2021)Nicolas Huot · Institut Pasteur3 papers (2018–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Virology · Immunology →